-
Exact Sciences Corporation (EXAS $63.50)
-
Invitae Corporation (NVTA)
-
CRISPR Therapeutics AG (CRSP $65.72)
Q: Between NVTA, CRSP, EXAS which one will prefer to start a new position - from a quality of product and pipeline - runway and performance perspective. Thanks